Zinani, Dakota B.
Desai, Jhanvi N.
Norman, Andrew B.
Funding for this research was provided by:
National Institutes of Health (U01DA050330)
Article History
Received: 25 May 2023
Accepted: 24 August 2023
First Online: 4 September 2023
Competing interests
: ABN is a coinventor on a series of patents on the matter and use of the h2E2 monoclonal antibody. All other authors declare they have no conflicts of interest.